Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-DZHK20): Trial Design and Experience at UKSH Lübeck.
Saved in:
| Title: | Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-DZHK20): Trial Design and Experience at UKSH Lübeck. |
|---|---|
| Authors: | Ensminger, S.1 (AUTHOR), Fujita, B.2 (AUTHOR), Aboud, A.3 (AUTHOR), Paitazoglou, C.3 (AUTHOR), Eitel, I.3 (AUTHOR), Jurczyk, D.4 (AUTHOR), Mezger, M.4 (AUTHOR), Yebran, F.5 (AUTHOR), Kutschka, I.5 (AUTHOR), Tiburcy, M.5 (AUTHOR), Legler, T.5 (AUTHOR), Riggert, J.5 (AUTHOR), Placzek, M.5 (AUTHOR), Friede, T.5 (AUTHOR), Jebran, A.F.6 (AUTHOR), Seidler, T.5 (AUTHOR), Zimmermann, W.H.5 (AUTHOR) |
| Source: | Thoracic & Cardiovascular Surgeon. 2024 Supplement1, Vol. 72, pS1-S68. 68p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01716425 |
|---|---|
| DOI: | 10.1055/s-0044-1780639 |
